Eli Lilly & Co. (LLY) Dividend History

Eli Lilly & Co. is a global pharmaceutical company founded in 1876, focused on developing innovative medicines in areas such as oncology, neuroscience, diabetes, and immunology. The company is known for its research-driven approach and has a strong portfolio of prescription drugs and biologics aimed at improving patient health worldwide.

Lilly Corporate Ctr, Indianapolis, IN, 46285
Phone: (317) 276-2000
Website: https://www.lilly.com

Dividend Yield: 0.72%

Dividend Frequency: Quarterly

Dividend History

Pay Date	Amount	Ex Dividend Date	Record Date
September 10, 2025	$1.50	08/15/2025	08/15/2025
June 10, 2025	$1.50	05/16/2025	05/16/2025
March 10, 2025	$1.50	02/14/2025	02/14/2025
December 10, 2024	$1.30	11/15/2024	11/15/2024
September 10, 2024	$1.30	08/15/2024	08/15/2024
June 10, 2024	$1.30	05/15/2024	05/16/2024
March 08, 2024	$1.30	02/14/2024	02/15/2024
December 08, 2023	$1.13	11/14/2023	11/15/2023
September 08, 2023	$1.13	08/14/2023	08/15/2023
June 09, 2023	$1.13	05/12/2023	05/15/2023
March 10, 2023	$1.13	02/14/2023	02/15/2023
December 09, 2022	$0.98	11/14/2022	11/15/2022
September 09, 2022	$0.98	08/12/2022	08/15/2022
June 10, 2022	$0.98	05/13/2022	05/16/2022
March 10, 2022	$0.98	02/14/2022	02/15/2022
December 10, 2021	$0.85	11/12/2021	11/15/2021
September 10, 2021	$0.85	08/12/2021	08/13/2021
June 10, 2021	$0.85	05/13/2021	05/14/2021
March 10, 2021	$0.85	02/11/2021	02/12/2021
December 10, 2020	$0.74	11/12/2020	11/13/2020
September 10, 2020	$0.74	08/13/2020	08/14/2020
June 10, 2020	$0.74	05/14/2020	05/15/2020
March 10, 2020	$0.74	02/13/2020	02/14/2020
December 10, 2019	$0.64	11/14/2019	11/15/2019
September 10, 2019	$0.64	08/14/2019	08/15/2019
June 10, 2019	$0.64	05/16/2019	05/17/2019
March 08, 2019	$0.64	02/14/2019	02/15/2019
December 10, 2018	$0.56	11/14/2018	11/15/2018
September 10, 2018	$0.56	08/14/2018	08/15/2018
June 08, 2018	$0.56	05/16/2018	05/17/2018
March 09, 2018	$0.56	02/14/2018	02/15/2018
December 08, 2017	$0.52	11/14/2017	11/15/2017
September 08, 2017	$0.52	08/11/2017	08/15/2017
June 09, 2017	$0.52	05/11/2017	05/15/2017
March 10, 2017	$0.52	02/13/2017	02/15/2017
December 09, 2016	$0.51	11/10/2016	11/15/2016
September 09, 2016	$0.51	08/11/2016	08/15/2016
June 10, 2016	$0.51	05/11/2016	05/13/2016
March 10, 2016	$0.51	02/10/2016	02/12/2016
December 10, 2015	$0.50	11/10/2015	11/13/2015
September 10, 2015	$0.50	08/12/2015	08/14/2015
June 10, 2015	$0.50	05/14/2015	05/18/2015
March 10, 2015	$0.50	02/11/2015	02/13/2015
December 10, 2014	$0.49	11/12/2014	11/14/2014
September 10, 2014	$0.49	08/13/2014	08/15/2014
June 10, 2014	$0.49	05/13/2014	05/15/2014
March 10, 2014	$0.49	02/12/2014	02/14/2014
December 10, 2013	$0.49	11/13/2013	11/15/2013
September 10, 2013	$0.49	08/13/2013	08/15/2013
June 10, 2013	$0.49	05/14/2013	05/16/2013
March 08, 2013	$0.49	02/13/2013	02/15/2013
December 10, 2012	$0.49	11/13/2012	11/15/2012
September 10, 2012	$0.49	08/13/2012	08/15/2012
June 08, 2012	$0.49	05/11/2012	05/15/2012
March 09, 2012	$0.49	02/13/2012	02/15/2012
December 09, 2011	$0.49	11/10/2011	11/15/2011
September 09, 2011	$0.49	08/11/2011	08/15/2011
June 10, 2011	$0.49	05/11/2011	05/13/2011
March 10, 2011	$0.49	02/11/2011	02/15/2011
December 10, 2010	$0.49	11/10/2010	11/15/2010
September 10, 2010	$0.49	08/11/2010	08/13/2010
June 10, 2010	$0.49	05/12/2010	05/14/2010
March 10, 2010	$0.49	02/10/2010	02/12/2010
December 10, 2009	$0.49	11/10/2009	11/13/2009
September 10, 2009	$0.49	08/12/2009	08/15/2009
June 10, 2009	$0.49	05/13/2009	05/15/2009
March 10, 2009	$0.49	02/11/2009	02/13/2009
December 10, 2008	$0.47	11/12/2008	11/14/2008
September 10, 2008	$0.47	08/13/2008	08/15/2008
June 10, 2008	$0.47	05/13/2008	05/15/2008
March 10, 2008	$0.47	02/13/2008	02/15/2008
December 10, 2007	$0.43	11/13/2007	11/15/2007
September 10, 2007	$0.43	08/13/2007	08/15/2007
June 08, 2007	$0.43	05/11/2007	05/15/2007
March 09, 2007	$0.43	02/13/2007	02/15/2007
December 08, 2006	$0.40	11/13/2006	11/15/2006
September 08, 2006	$0.40	08/11/2006	08/15/2006
June 09, 2006	$0.40	05/11/2006	05/15/2006
March 10, 2006	$0.40	02/13/2006	02/15/2006
December 09, 2005	$0.38	11/10/2005	11/15/2005
September 09, 2005	$0.38	08/11/2005	08/15/2005
June 10, 2005	$0.38	05/11/2005	05/13/2005
March 10, 2005	$0.38	02/11/2005	02/15/2005
December 10, 2004	$0.35	11/10/2004	11/15/2004
September 10, 2004	$0.35	08/11/2004	08/13/2004
June 10, 2004	$0.35	05/12/2004	05/14/2004
March 10, 2004	$0.35	02/11/2004	02/13/2004

Dividends Summary

Eli Lilly & Co. has issued 87 dividend payments over the past 21 years
The most recent dividend was paid 24 days ago, on June 10, 2025
The first recorded dividend was paid on March 10, 2004
The highest dividend payout was $1.50 per share
The average dividend over this 21 year span is $0.64 per share
Eli Lilly & Co. has increased its dividend payments by 322.54% since 2004

Company News

Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity

Viking Therapeutics is developing VK2735, an oral GLP-1/GIP receptor agonist for obesity treatment with unprecedented tolerability. Early phase 2 results show 14.7% weight loss and a unique 13% discontinuation rate matching placebo, potentially revolutionizing obesity drug market.

The Motley Fool

Featured Companies: AMGN PFE VKTX
Microservices in Healthcare Market Size to Hit USD 1,905.26 Million by 2032, Driven by Cloud Adoption and Healthcare Digitization – SNS Insider

The microservices in healthcare market is projected to grow from USD 334.59 million in 2023 to USD 1,905.26 million by 2032, with a CAGR of 21.34%, driven by cloud adoption, digital health initiatives, and healthcare digitization.

GlobeNewswire Inc.

Featured Companies: ORCL PFE
McDonald’s Is Down, but Long-Term Investors Can Still Take a Bite

McDonald's stock has declined due to the impact of GLP-1 drugs, high prices, and a trend towards healthier eating. However, the stock's valuation and dividend make it an attractive long-term investment opportunity.

Investing.com

Featured Companies: MCD
Eli Lilly Expands Into Gene Editing With Verve Therapeutics Acquisition

Eli Lilly has agreed to acquire Verve Therapeutics, a clinical-stage company developing gene editing medicines for cardiovascular disease. The $1.3 billion deal offers a significant premium for Verve's shareholders.

Benzinga

Featured Companies: VERV

Page data last updated 07/04/2025 22:12:03 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included

Eli Lilly & Co. (LLY) Dividend History

Dividend History

Dividends Summary

Company News

Related Companies